Belcolle Hospital

Running trials

• Recruiting

  Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

  NCT05817903· Phase 2· Source

• Active, not recruiting

  Trial in AML Secondary to MPNs Patients, Unfit for Intensive Chemotherapy, Investigating a Treatment Combination Including Decitabine and Venetoclax

  NCT04763928· Phase 2· Source

• Recruiting

  Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)

  NCT04184505· Phase 3· Source

• Recruiting

  Study to identify the most appropriate therapy for patients with Acute Myeloid Leukemia carrying FLT3 mutation, using the PBC biomarker to customize therapy.

  NCT04174612· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukemia1 recruiting
• Kidney cancer1 recruiting
• Myelodysplastic syndromes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Active, not recruiting

  Trial of Sibeprenlimab in the Treatment of A Nephropathy (IgAN)

  NCT05248646· Phase 3· Source